Data are processed for the conduct of the carbapenem- and/or colistin-resistant Enterobacteriaceae (CCRE) survey as part of molecular surveillance of antimicrobial resistant pathogens according to a protocol. For the CCRE survey bacterial isolates (carbapenem and/or colistin-resistant Enterobacteriaceae and susceptible control isolates) and related patient data are collected in hospitals in 37 countries with the aim to determine transmission pathways and improve control measures.
The aim of this evaluation was to review the implementation, determine the lessons learnt and formulate recommendations to strengthen ECDC’s capacity to mobilise experts for field deployment to support future outbreak response initiatives, both in and outside the EU.